Joji B Kuramatsu
Overview
Explore the profile of Joji B Kuramatsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mrochen A, Song Y, Harders V, Sembill J, Sprugel M, Hock S, et al.
Front Neurol
. 2024 Aug;
15:1357815.
PMID: 39161870
Background And Aims: General guideline recommendations in patients with intracerebral hemorrhage (ICH) include blood pressure-, temperature- and glucose management. The therapeutic effect of such a "care bundle" (blood pressure lowering,...
2.
Sembill J, Sprugel M, Haupenthal D, Kremer S, Knott M, Muhlen I, et al.
Neurol Res Pract
. 2024 Jul;
6(1):37.
PMID: 39049127
Background: Endovascular thrombectomy (EVT) has been proven effective in anterior circulation stroke due to large vessel occlusion (LVO). However, translation from randomized clinical trials (RCTs) with highly selected patients to...
3.
Anisocoria After Direct Light Stimulus is Associated with Poor Outcomes Following Acute Brain Injury
Doyle B, Aiyagari V, Yokobori S, Kuramatsu J, Barnes A, Puccio A, et al.
Neurocrit Care
. 2024 Jun;
41(3):1020-1026.
PMID: 38918339
Background: Assessing pupil size and reactivity is the standard of care in neurocritically ill patients. Anisocoria observed in critically ill patients often prompts further investigation and treatment. This study explores...
4.
Berberich A, Herweh C, Qureshi M, Strambo D, Michel P, Raty S, et al.
J Neurointerv Surg
. 2024 Jun;
PMID: 38839282
Background: The optimal anesthetic strategy for endovascular therapy (EVT) in acute ischemic stroke is still under debate. The aim of this study was to compare the clinical outcomes of patients...
5.
Raty S, Nguyen T, Nagel S, Strambo D, Michel P, Herweh C, et al.
J Stroke
. 2024 Jun;
26(2):290-299.
PMID: 38836276
Background And Purpose: Posterior cerebral artery occlusion (PCAo) can cause long-term disability, yet randomized controlled trials to guide optimal reperfusion strategy are lacking. We compared the outcomes of PCAo patients...
6.
Strambo D, Michel P, Nguyen T, Abdalkader M, Qureshi M, Strbian D, et al.
Stroke
. 2024 May;
55(7):1787-1797.
PMID: 38753954
Background: Acute ischemic stroke with isolated posterior cerebral artery occlusion (iPCAO) lacks management evidence from randomized trials. We aimed to evaluate whether the association between endovascular treatment (EVT) and outcomes...
7.
Kolbl K, Hock S, Xu M, Sembill J, Mrochen A, Balk S, et al.
Front Neurol
. 2024 Jan;
14:1268839.
PMID: 38274884
Objective: Hematoma expansion (HE) is the most important therapeutic target during acute care of patients with intracerebral hemorrhage (ICH). Imaging biomarkers such as non-contrast CT (NCCT) markers have been associated...
8.
Giede-Jeppe A, Gerner S, Sembill J, Kuramatsu J, Lang S, Luecking H, et al.
Neurocrit Care
. 2023 Nov;
40(3):1089-1098.
PMID: 38030878
Background: Our objective was to test the association between hematoma volume and long-term (> 72 h) edema extension distance (EED) evolution and the association between peak EED and early EED...
9.
Saju C, Barnes A, Kuramatsu J, Marshall J, Obinata H, Puccio A, et al.
Am J Crit Care
. 2023 Oct;
32(6):402-409.
PMID: 37907374
Background: Anisocoria (unequal pupil size) has been defined using cut points ranging from greater than 0.3 mm to greater than 2.0 mm for absolute difference in pupil size. This study...
10.
Haupenthal D, Schwab S, Kuramatsu J
Neurol Res Pract
. 2023 Jul;
5(1):36.
PMID: 37496094
Background: The avoidance of hematoma expansion is the most important therapeutic goal during acute care of patients with intracerebral hemorrhage. Hematoma expansion occurs in up to 20-40% of patients and...